(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)
Terms and Conditions for Use
Click on image to view larger version.
View larger version (213K)
Figure 10a. Probable bleomycin toxicity in a 35-year-old man with Hodgkin disease who was treated with doxorubicin hydrochloride, bleomycin, vinblastine, and dacarbazine. (a) Coronal PET scan shows diffuse increased FDG uptake in the lungs. Note also the physiologic uptake in the myocardium and kidneys and the increased uptake in the bone marrow due to G-CSF therapy. (b) Axial PET scan shows increased FDG uptake at the periphery of the lungs. (c) CT scan shows diffuse ground-glass attenuation.
